BMs from melanoma, kidney, lung, ovarian and breast cancers had significantly more frequent HER2-HER3 dimers than normal reference tissues (p ≤ 0.01 by Kruskal–Wallis test; Figure 2d). This evidence concerns the gene ERBB2 and breast carcinoma.